Related Products
Some results have been hidden because they may be inaccessible to you.Show inaccessible results
NMOSD treatment | Terminal complement inhibition
SponsoredEfficacy data, safety and tolerability, dosing schedule, and vaccination requirements. FDA-approved treatment for anti-AQP4 antibody-positive NMOSD.HCP Resources · Safety · Weight-based Dosing · REMS Program
Complement C5
SponsoredHigh homogeneity. Suitable for immunization, neutralizing antibody screening and more. High homogeneity and bioactivity verified. Protocols offered for free.Quick Reconstitution · Binds Anti-A35R Antibody · 65 Clinical Trials


Feedback